{
  "trial_id": "NCT03686124",
  "title": "ACTengine\u00ae IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors",
  "condition": "Refractory Cancer",
  "participant_count": 375,
  "bias_type": "mixed",
  "age_distribution": {
    "mean": 48.19466666666667,
    "std": 15.565523858091867,
    "min": 18,
    "max": 80
  },
  "gender_distribution": {
    "male": 0.5301852408390604,
    "female": 0.4698147591609396
  },
  "ethnicity_distribution": {
    "white": 0.7,
    "black": 0.15,
    "asian": 0.1,
    "hispanic": 0.04,
    "other": 0.01
  },
  "sample_size": 375,
  "eligibility_score": 0.8240050685028157
}